1. Home
  2. AIRE vs CALC Comparison

AIRE vs CALC Comparison

Compare AIRE & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo reAlpha Tech Corp.

AIRE

reAlpha Tech Corp.

HOLD

Current Price

$0.45

Market Cap

56.9M

Sector

N/A

ML Signal

HOLD

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$6.67

Market Cap

88.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRE
CALC
Founded
2021
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.9M
88.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AIRE
CALC
Price
$0.45
$6.67
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$2.00
$16.00
AVG Volume (30 Days)
6.0M
97.6K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,149,567.00
N/A
Revenue This Year
$456.19
N/A
Revenue Next Year
$105.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
994.18
N/A
52 Week Low
$0.14
$1.42
52 Week High
$2.89
$7.20

Technical Indicators

Market Signals
Indicator
AIRE
CALC
Relative Strength Index (RSI) 46.33 71.29
Support Level $0.40 $5.55
Resistance Level $0.60 $7.20
Average True Range (ATR) 0.05 0.69
MACD -0.00 0.07
Stochastic Oscillator 25.72 86.15

Price Performance

Historical Comparison
AIRE
CALC

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: